Search
                    Oregon Paid Clinical Trials
A listing of 1212  clinical trials  in Oregon  actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
            1189 - 1200 of 1212
        
                Oregon is currently home to 1212 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including Portland, Eugene, Medford and Clackamas. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
            
                                                Featured Trial
                
                Healthy Participants Needed (Colonoscopy + Cancer Screening)
            
        Recruiting
            
        Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
    
    
                            Conditions: 
                                    
        
            
                        Healthy
                    
                                    
                        Healthy Volunteers
                    
                                    
                        Healthy Subjects
                    
                                    
                        Healthy Volunteer
                    
                                    
                        Healthy Participants
                    
                                    Featured Offer
                
                Lose Weight with GLP-1 Medications
            
        Recruiting
            
        Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®. 
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
    GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
                            Conditions: 
                                    
        
            
                        Overweight
                    
                                    
                        Overweight and Obesity
                    
                                    
                        Obesity
                    
                                    
                        Weight Loss
                    
                                    
                        Morbid Obesity
                    
                                    Featured Trial
                
                Stroke Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Stroke
    
    
                            Conditions: 
                                    
        
            
                        Stroke
                    
                                    Featured Trial
                
                Chronic Kidney Disease (CKD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Chronic Kidney Disease (CKD)
    
    
                            Conditions: 
                                    
        
            
                        Chronic Kidney Disease (CKD)
                    
                                    Featured Trial
                
                Cardiovascular Disease Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Cardiovascular Disease
    
    
                            Conditions: 
                                    
        
            
                        Cardiovascular Disease
                    
                                    
                
                                    Non-Invasive At-Home Sleep Therapy System
                                
            
            
        Recruiting
                            
            
                The goal of this clinical trial is to learn about the ability of non-invasive brain stimulation during sleep to enhance people's deep sleep and its potential benefit on memory in healthy adults via home use sleep therapy device (SleepWISP). Participants will be asked to wear non-invasive and painless devices that record their brain activity during sleep. The clinical trial aims to answer the following main questions:
1. Whether the non-invasive transcranial electrical stimulation (TES) delivere...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 22 years and 85 years
            Trial Updated:
                07/31/2023
            
            Locations: Brain Electrophysiology Laboratory Company, Eugene, Oregon         
        
        
            Conditions: Sleep, Sleep Duration, Sleep Quality
        
            
        
    
                
                                    Adoptive Cell Therapy Using Cancer Specific CD8+ Tumor Infiltrating Lymphocytes in Adult Patients With Solid Tumors
                                
            
            
        Recruiting
                            
            
                The subject of this study is the adoptive transfer of selected autologous tumor infiltrating lymphocytes (TIL) after in vitro expansion for the treatment of solid tumor malignancies. The TIL selection process is based on evidence showing that CD8+ TIL which co-express both CD39 and CD103 harbor the bulk of tumor-reactivity and that the remaining CD8 TIL is mainly composed of non-tumor reactive bystander cells. All of the expanded TIL that are produced (1-40 billion are expected) will be delivere...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                07/18/2023
            
            Locations: Providence Portland Medical Center, Portland, Oregon         
        
        
            
        
    
                
                                    Bringing Weight Management Into the Primary Care Pediatric Practice
                                
            
            
        Recruiting
                            
            
                This project aims to move what is currently a specialty-care model for the management of obesity of children and adolescents into the primary care setting.             
        
        
    Gender:
                ALL
            Ages:
                Between 1 month and 21 years
            Trial Updated:
                07/17/2023
            
            Locations: The Children's Clinic, Portland, Oregon         
        
        
            Conditions: Obesity, Childhood
        
            
        
    
                
                                    Ovarian Tissue Freezing For Fertility Preservation
                                
            
            
        Recruiting
                            
            
                The purpose of this study is to offer an alternative method to women who wish to preserve the possibility of fertility, as well as to learn more about the ability of human eggs to survive and function after long term storage in frozen ovaries (ovarian tissue cryopreservation). The study will seek to preserve ovarian tissue and reproductive potential for patients whose medical or surgical treatment may harm ovaries or remove ovarian tissue.             
        
        
    Gender:
                FEMALE
            Ages:
                Between 18 years and 41 years
            Trial Updated:
                06/30/2023
            
            Locations: Oregon Health and Sciences Universtiy, Portland, Oregon         
        
        
            Conditions: Malignancy, Fertility
        
            
        
    
                
                                    The Work-life Check-ins: a Supervisor-driven Intervention to Reduce Burnout in Primary Care
                                
            
            
        Recruiting
                            
            
                The objective of this study is to evaluate the effectiveness and process of frequent supervisor-employee check-ins in reducing burnout among employees of primary care clinics in Portland, OR. Healthcare workers are at risk for burnout and associated adverse health and safety outcomes, including chronic diseases and occupational injuries. Not only does burnout affect healthcare workers, but burnout also affects the quality of patient care. The proposed study will create a check-in process between...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                06/27/2023
            
            Locations: OHSU, Portland, Oregon         
        
        
            Conditions: Burnout
        
            
        
    
                
                                    Electromagnetic Fields Versus Placebo For Child-Pugh A and B Patients With Advanced Hepatocellular Carcinoma
                                
            
            
        Recruiting
                            
            
                The primary goals of this study are to compare overall survival and quality of life in subjects with Child-Pugh A or B advanced hepatocellular carcinoma when treated with a device emitting radiofrequencies modulated at specific frequencies or with a device emitting unmodulated radiofrequencies.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                06/25/2023
            
            Locations: Oregon Health & Science University, Knight Cancer Institute, Portland, Oregon         
        
        
            Conditions: Hepatocellular Carcinoma
        
            
        
    
                
                                    AMP SCZ® Observational Study: PREDICT-DPACC
                                
            
            
        Recruiting
                            
            
                The Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ) is a large international collaboration to develop algorithms using a set of clinical and cognitive assessments, multi-modal biomarkers, and clinical endpoints that can be used to predict the trajectories and outcomes of individuals at clinical high risk (CHR) for psychosis and to advance the testing of pharmacological interventions for CHR individuals in need. The goal is to accurately predict which individuals are likely to remit,...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 12 years and 30 years
            Trial Updated:
                06/06/2023
            
            Locations: University of Oregon, Eugene, Oregon         
        
        
            Conditions: Clinical High Risk, Psychosis, Remission, Conversion
        
            
        
    
                
                                    Students With Involved Families and Teachers
                                
            
            
        Recruiting
                            
            
                PURPOSE: In the proposed project, the investigators seek to examine whether the SWIFT Program might be efficacious to improve students' prosocial skills and emotion and behavior regulation and improve home-school communication and the use of positive parenting practices for families. The investigators will also test whether the SWIFT program might be efficacious to improve students' longer-term school adjustment and parents' involvement in school.
SETTING: Study activities will take place in te...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 10 years and 16 years
            Trial Updated:
                05/26/2023
            
            Locations: Oregon Social Learning Center, Eugene, Oregon         
        
        
            Conditions: Emotional Regulation, Adolescent Behavior, Parenting
        
            
        
    
                
                                    Allogeneic NK T-Cells Expressing CD19 Specific CAR in B-Cell Malignancies
                                
            
            
        Recruiting
                            
            
                This study is a multi-center study to evaluate the safety of KUR-502 in subjects with refractory/relapsed B-cell NHL or leukemia (ALL or CLL).             
        
        
    Gender:
                ALL
            Ages:
                Between 3 years and 75 years
            Trial Updated:
                05/16/2023
            
            Locations: OHSU - Knight Cancer Center, Portland, Oregon         
        
        
            Conditions: NHL, Relapsed, Adult, B-cell Lymphoma, B-cell Leukemia, DLBCL - Diffuse Large B Cell Lymphoma, ALL, Adult B Cell, ALL, Childhood, CLL/SLL
        
            
        
    
                
                                    KRT-232 Versus Best Available Therapy for the Treatment of Subjects With Myelofibrosis Who Are Relapsed or Refractory to JAK Inhibitor Treatment
                                
            
            
        Recruiting
                            
            
                This study evaluates KRT-232, a novel oral small molecule inhibitor of MDM2, for the treatment of patients with myelofibrosis (MF) who no longer benefit from treatment with a JAK inhibitor. Inhibition of MDM2 is a novel mechanism of action in MF.
This study will be conducted in 2 phases. Phase 2 will determine the KRT-232 recommended dose and dosing schedule; Phase 3 will test KRT-232 vs Best Available Therapy (BAT). Patients in the Phase 3 part of the study will be randomized 2:1 to receive ei...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                04/26/2023
            
            Locations: Oregon Health and Science University, Portland, Oregon         
        
        
            Conditions: Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Post-Essential Thrombocythemia MF (Post-ET-MF)
        
            
        
    
                
                                    Functional and Structural Imaging for Glaucoma
                                
            
            
        Recruiting
                            
            
                The specific aims of the clinical studies are to:
* Develop a directional high-resolution OCT and OCT angiography prototype to improve imaging of structure and perfusion.
* Validate wide-field OCT and OCT angiography parameters to improve early glaucoma detection.
* Simulate visual field results by combining structural and angiography OCT data.
* Assess abilities of above technologies and OCT-derived parameters on predicting glaucoma detection, conversion, and progression.             
        
        
    Gender:
                ALL
            Ages:
                Between 40 years and 85 years
            Trial Updated:
                04/17/2023
            
            Locations: Oregon Health & Science University, Casey Eye Institute, Portland, Oregon         
        
        
            Conditions: Glaucoma
        
            
        
    
                
                                    Eye Pressure Lowering Surgery
                                
            
            
        Recruiting
                            
            
                The purpose of this study is to determine if lowering the pressure inside the eye improves blood flow to the eye.             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 85 years
            Trial Updated:
                04/17/2023
            
            Locations: OHSU, Portland, Oregon         
        
        
            Conditions: Glaucoma
        
            
        
    